Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.
about
Tackling Drug Resistant Infection Outbreaks of Global Pandemic Escherichia coli ST131 Using Evolutionary and Epidemiological Genomics.Global Phenotypic Characterization of Effects of Fluoroquinolone Resistance Selection on the Metabolic Activities and Drug Susceptibilities of Clostridium perfringens StrainsQuinolone resistance and ornithine decarboxylation activity in lactose-negative Escherichia coli.The impact of drug resistance on Mycobacterium tuberculosis physiology: what can we learn from rifampicin?Collateral sensitivity of antibiotic-resistant microbes.DNA supercoiling is a fundamental regulatory principle in the control of bacterial gene expression.Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant Escherichia coli.Parallel evolutionary pathways to antibiotic resistance selected by biocide exposure.Elevated mutagenesis does not explain the increased frequency of antibiotic resistant mutants in starved aging colonies.Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli.Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network.SOLITAIRE-IV: A Randomized, Double-Blind, Multicenter Study Comparing the Efficacy and Safety of Intravenous-to-Oral Solithromycin to Intravenous-to-Oral Moxifloxacin for Treatment of Community-Acquired Bacterial Pneumonia.Environmental factors influencing the development and spread of antibiotic resistance.
P2860
Q30393531-320C1632-1B83-4484-89BC-8552D9E7BBC3Q34815324-E40243D5-18F4-4BFF-AEA1-15A4254BA529Q36057372-938AB44D-7F16-4A58-927F-C41AF1576A02Q37683485-AE24F246-0FA6-45E6-A861-D0F422D6D3DCQ38394500-4798C891-3518-413C-809D-B6D60BD7AC74Q39310921-DD15732D-133A-4153-9E47-68D07F3AD717Q41052192-05C73256-3717-4A4D-810B-2ACD513CF361Q41249530-805F2921-B8A6-481C-9DC4-10C90F31D9A6Q41855236-60BDF546-0110-4DB2-9600-C0EFC6782E1FQ42201141-4783F9B8-BAD8-4533-B070-BF2D9C9699C4Q42738785-E30DECCB-E91A-4DA2-A58E-A4E6FCB21A8AQ45938233-D9973E34-BE12-4192-BCA5-98E280001586Q47631000-3B7E817E-CD29-4843-9C24-2CF808EDB0CE
P2860
Clinically relevant mutant DNA gyrase alters supercoiling, changes the transcriptome, and confers multidrug resistance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinically relevant mutant DNA ...... confers multidrug resistance.
@en
Clinically relevant mutant DNA ...... confers multidrug resistance.
@nl
type
label
Clinically relevant mutant DNA ...... confers multidrug resistance.
@en
Clinically relevant mutant DNA ...... confers multidrug resistance.
@nl
prefLabel
Clinically relevant mutant DNA ...... confers multidrug resistance.
@en
Clinically relevant mutant DNA ...... confers multidrug resistance.
@nl
P2093
P2860
P50
P356
P1433
P1476
Clinically relevant mutant DNA ...... d confers multidrug resistance
@en
P2093
Maria Fookes
Meha Patel
Rebekah Whitehead
P2860
P356
10.1128/MBIO.00273-13
P577
2013-07-23T00:00:00Z